Resuscitation of the Morbidly Obese Patient

American Journal of Emergency Medicine

Volumn 22, Issue 1, 2004, Pages 40-47

  Brunette, Douglas D ^a  

^a HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Critical care; Obesity; Resuscitation

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; ATRACURIUM; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CORTICOSTEROID; DIGOXIN; ESMOLOL; ETOMIDATE; FENTANYL; KETAMINE; LABETALOL; METHOHEXITAL; METHYLPREDNISOLONE; METOPROLOL; MORPHINE; PHENOBARBITAL; PHENYTOIN; PROPOFOL; PROPRANOLOL; REMIFENTANIL; ROCURONIUM; SEDATIVE AGENT; SUFENTANIL; SUXAMETHONIUM; THIOPENTAL; UNINDEXED DRUG; VALPROIC ACID; VECURONIUM;

BODY MASS; CRITICAL ILLNESS; EMERGENCY TREATMENT; HUMAN; INCIDENCE; INJURY; METHODOLOGY; MORBID OBESITY; OBESITY; PRIORITY JOURNAL; RESUSCITATION; REVIEW; UNITED STATES;

EID: 0742323179     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(02)42250-4     Document Type: Article

References (126)

1. Flegal KM, Carroll MD, Kuczmarski RJ, et al: Overweight and obesity in the United States: Prevalence and trends, 1960-1994. Int J Obes Relat Metab Disord 1998;22:39-47
2. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - The evidence report. National Heart, Lung, and Blood Institute, National Institutes of Health June 1998
3. Calle EE, Thun MJ, Petrelli JM, et al: Body-mass index and mortality in a prospective cohort of U S adults. N Engl J Med 1999;341:1097-1105
4. Allison DB, Fontaine KR, Manson JE, et al: Annual deaths attributable to obesity in the United States. JAMA 1999;282:1530-1538
5. Berthoud MC, Peacock JE, Reilly CS: Effectiveness of preoxygenation in morbidly obese patients. Br J Anaesth 1991;67:464-466
6. Ray C, Sue D, Bray G, et al: Effect of obesity on respiratory function. Am Rev Respir Dis 1983;128:501-506
7. Zerah F, Harf A, Perlemuter L, et al: Effects of obesity on respiratory resistance. Chest 1993;103:1470-1476
8. Vaughan RW, Conaham TJI: Part I. Cardiopulmonary consequences of morbid obesity. Life Sci 1980;26:2119-2127
9. Thomas PS, Cowen ERT, Hulands G, et al: Respiratory function in the morbidly obese before and after weight loss. Thorax 1989;44:382-386
10. Surratt P, Wilheit S, Hsiao H: Compliance of the chest wall in obese subjects. J Appl Physiol 1984;57:403-409
11. Vaughan RW, Bauer S, Wise L: Volume and pH of gastric juice in obese patients. Anesthesiology 1975;43:686-689
12. Williamson JA, Webb RK, Szekely S, et al: The Australian Incident Monitoring Study. Difficult intubation: An analysis of 2,000 incident reports. Anaesth Intens Care 1993;21:602-607
13. Rocke DA, Murray WB, Rout CC, et al: Relative risk analysis of factors associated with difficult intubation in obstetric anesthesia. Anesthesiology 1992;77:67-73
14. Mallampati SR, Gatt SP, Gugino LD, et al: A clinical sign to predict difficult tracheal intubation: A prospective study. Can Anaesth Soc J 1985;32:429-434
15. Levitan R, Ochroch EA: Airway management and direct laryngoscopy. A review and update. Criti Care Clin 2000;16:373-388
16. Roppolo LP, Vilke GM, Chan TC, et al: Nasotracheal intubation in the emergency department, revisited. J Emerg Med 1999;17: 791-799 [published erratum appears in J Emerg Med 2000;18:145]
17. Roppolo LP, Vilke GM, Chan TC, et al: Nasotracheal intubation in the emergency department, revisited. J Emerg Med 1999;17: 791-799 [published erratum appears in J Emerg Med 2000;18:145]
18. Van Elstraete AC, Mamie JC, Mehdaoui H: Nasotracheal intubation in patients with immobilized cervical spine: A comparison of tracheal tube cuff inflation and fiberoptic bronchoscopy. Anesth Analg 1998;87:400-402
19. Ho AM, Wong H, Ling E, et al: Airway difficulties caused by improperly applied cricoid pressure. J Emerg Med 2001;20:29-31
20. Aye T, Milne B: Use of the laryngeal mask prior to definitive intubation in a difficult airway: A case report. J Emerg Med 1995; 13:711-714
21. Banyai M, Falger S, Roggla M, et al: Emergency intubation with the Combitube in a grossly obese patient with bull neck. Resuscitation 1993;26:271-276
22. Rosenblatt WH, Murphy M: The intubating laryngeal mask: Use of a new ventilating-intubating device in the emergency department. Ann Emerg Med 1999;33:234-238
23. Reed AP: The unanticipated difficult airway. Anesthesiology Clin North Am 1996;14:443-469
24. Hung O, Pytka S, Morris I, et al: Lightwands intubation: II; Clinical trial of a new lightwand for tracheal intubation in patients with difficult airways. Can J Anesth 1995;42:826-830
25. Patel RG: Percutaneous transtracheal jet ventilation. Chest 1999;116:1689-1694
26. Mansharamani NG, Koziel H, Garland R, et al: Safety of bedside percutaneous dilatational tracheostomy in obese patients in the ICU. Chest 2000;117:1426-1429
27. Naimark A, Cherniack RM: Compliance of the respiratory system and its components in health and obesity. J Appl Physiol 1960;15:377-382
28. Sharp JT, Henry JP, Sweany SK: Effects of mass loading the respiratory system in man. J Appl Physiol 1964;19:959-966
29. Holley HS, Milic-Emili J, Becklake MR: Regional distribution of pulmonary ventilation and perfusion in obesity. J Clin Invest 1967;46:475-481
30. Sahebjami H, Gartside PS: Pulmonary function in obese subjects with a normal FEV1/FVC ratio. Chest 1996;110:1425-1429
31. Sahebjami H: Dyspnea in obese healthy men. Chest 1998; 114:1373-1377
32. Pelosi P, Croci M, Ravagnan I, et al: The effects of body mass on lung volumes, respiratory mechanics, and gas exchange during general anesthesia. Anesth Analg 1998;87:654-660
33. Pelosi P, Croci M, Ravagnan I, et al: Respiratory system mechanics in sedated, paralyzed, morbidly obese patients. J Appl Physiol 1997;82:811-818
34. Pelosi P, Croci M, Calappi E, et al: Prone positioning improves pulmonary function in obese patients during general anesthesia. Anesth Analg 1996;83:578-583
35. Marik P, Varon J: The obese patient in the ICU. Chest 1998; 113:492-498
36. Pelosi P, Ravagnan I, Giurati G, et al: Positive end-expiratory pressure improves respiratory function in obese but not in normal subjects during anesthesia and paralysis. Anesthesiology 1999;91: 1221-1231
37. Vissers RJ, Raftery KA: The morbidly obese patient, in Tintinalli JE, Kelen GD, Stapczynski JS (Eds): Emergency medicine: A comprehensive study guide, 5th ed. New York: McGraw-Hill, 2000
38. Alpert MA, Lambert CR, Terry BE, et al: Influence of left ventricular mass on left ventricular diastolic filling in normotensive morbid obesity. Am Heart J 1995;130:1068-1073
39. Alpert MA: Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome. Am J Med Sci 2001;321:225-236
40. Alaud-din A, Meterissian S, Lisbona R, et al: Assessment of cardiac function in patients who were morbidly obese. Surgery 1990;108:809-818
41. Ferraro S, Perrone-Filardi P, Desiderio A, et al: Left ventricular systolic and diastolic function in severe obesity: A radionuclide study. Cardiology 1996;87:347-353
42. Alpert MA, Hashimi MW: Obesity and the heart. Am J Med Sci 1993;306:117-123
43. Bharati S, Lev M: Cardiac conduction system involvement in sudden death of obese young people. Am Heart J 1995;129:273-281
44. Alpert MA, Terry BE, Cohen MV, et al: The electrocardiogram in morbid obesity. Am J Cardiol 2000;85:908-910
45. Maxwell MH, Waks AU, Schroth PC, et al: Error in blood pressure measurement due to incorrect cuff size in obese patients. Lancet 1982;2:33-36
46. Boulanger BR, Milzman DP, Rodriguez A: Obesity. Crit Care Clin 1994;10:613-622
47. Gilbert TB, Seneff MG, Becker RB: Facilitation of internal jugular venous cannulation using an audio-guided doppler ultrasound vascular access device: Results from a prospective, dual center, randomized, crossover clinical study. Crit Care Med 1995; 23:60-65
48. Gratz I, Afshar M, Kidwell P, et al: Doppler guided cannulation of the internal jugular vein: A prospective randomized trial. J Clin Monit 1994;10:185-188
49. Gallieni M, Cozzolino M: Uncomplicated central vein catheterization of high risk patients with real time ultrasound guidance. Int J Artif Organs 1995;18:117-121
50. Varon J, Marik P: Management of the obese critically ill patient. Crit Care Clin 2001;17:187-200
51. Boulanger BR, Brenneman FD, Kirkpatrick AW, et al: The indeterminate abdominal sonogram in multisystem blunt trauma. J Trauma 1988;45:52-56
52. Melanson SW, Heller M: The emerging role of bedside ultrasonography in trauma care. Emerg Med Clin North Am 1998;16:165-189
53. McKenney KL: Ultrasound of blunt abdominal trauma. Radiol Clin North Am 1999;37:879-893
54. Brunette D: Twelve years of emergency medicine at HCMC: Changing critical care experience. Minn Med 1999;82:42-48
55. Ochsner MG, Herr D, Drucker W, et al: A modified Seldinger technique for peritoneal lavage in trauma patients who are obese. Surg Gynecol Obstet 1991;173:158-160
56. Abernethy DR, Greenblatt DJ: Pharmacokinetics of drugs in obesity. Clin Pharmacokinet 1982;7:108-124
57. Abernethy DR, Greenblatt DJ: Drug disposition in obese humans. An update. Clin Pharmacokinet 1986;11:199-213
58. Blouin RA, Kolpek JH, Mann HJ: Influence of obesity on drug disposition. Clin Pharm 1987;6:706-714
59. Girardin E, Bruguerolle B: Pharmacokinetic changes in obesity. Therapie 1993;48:397-402
60. Kotlyar M, Carson SW: Effects of obesity on the cytochrome P450 enzyme system. Int J Clin Pharmacol Ther 1999;37:8-19
61. Li L, Miles MV, Lakkis H, et al: Vancomycin-binding characteristics in patients with serious infections. Pharmacotherapy 1996; 16:1024-1029
62. Cheymol G: Clinical pharmacokinetics of drugs in obesity. Clinical Pharmacokinet 1993;25:103-114
63. Cheymol G: Drug pharmacokinetics in the obese. Fundam Clin Pharmacol 1988;2:239-256
64. Morgan DJ, Bray KM: Lean body mass as a predictor of drug dosage: Implications for drug therapy. Clin Pharmacokinet 1994;26: 292-307
65. Cheymol G: Effects of obesity on pharmacokinetcs implications for drug therapy. Clin Pharmacokinet 2000;39:215-231
66. Salazar DE, Corcoran GB: Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass. Am J Med 1988;84:1053-1060
67. Snider RD, Kruse JA, Bander JJ, et al: Accuracy of estimated creatinine clearance in obese patients with stable renal function in the intensive care unit. Pharmacotherapy 1995;15:747-753
68. Bouillon T, Shafer SL: Does size matter? Anesthesiology 1998;89:557-560
69. Wurtz R, Itokazu G, Rodvold K: Antimicrobial dosing in obese patients. Clin Infect Dis 1997;25:112-118
70. Bentley JB, Borel JD, Vaughan RW, et al: Weight, pseudocholinesterase activity, and succinylcholine requirement. Anesthesiology 1982;57:48-49
71. Rose JB, Theroux MC, Katz MS: The potency of succinylcholine in obese adolescents. Anesth Analg 2000;90:576-578
72. Schwartz AE, Mattco RS, Ornstein E, et al: Pharmacokinetics and pharmacodynamics of vecuronium in the obese surgical patient. Anesth Analge 1992;74:515-518
73. Weinstein JA, Matteo RS, Ornstein E, et al: Pharmacodynamics of vecuronium and atracurium in the obese surgical patient. Anesth Analge 1988;67:1149-1153
74. Varin F, Ducharme J, Theoret Y, et al: Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium. Clin Pharmacol Ther 1990;48:18-25
75. Puhringer FK, Khuenl-Brady KS, Mitterschiffthaler G: Rocuronium bromide: time course of action in underweight, normal weight, overweight, and obese patients. Eur J Anaesth Suppl 1995; 11:107-110
76. Puhringer FK, Keller C, Kleinsasser A, et al: Pharmacokinetics of rocuronium bromide in obese female patients. Eur J Anaesth 1999;16:107-110
77. Greenblatt DJ, Abernethy DR, Locniskar A, et al: Efect of age, gender, and obesity on midazolam kinetics. Anesthesiology 1984; 61:27-35
78. Abernethy DR, Greenblatt DJ, Divoll M, et al: Prolonged accumulation of diazepam in obesity. J Clin Pharmacol 1983;23:369-376
79. Abernethy DR, Greenblatt DJ, Divoll M, et al: The influence of obesity on the pharmacokinetics of oral alprazolam and triazolam. Clin Pharmacokinet 1984;9:177-183
80. Servin F, Farinotti R, Haberer JP, et al: Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. A clinical and pharmacokinetic study. Anesthesiology 1993;78:657-665
81. Lind L: The influence of obesity and fat distribution on induction and maintenance doses of propofol. Uppsala J Med Sci 1993; 98:187-188
82. Kazama T, Ikeda K, Morita K, et al: Relation between initial blood distribution volume and propofol induction dose requirement. Anesthesiology 2001;94:205-210
83. Gepts E, Camu F, Cockshott ID, et al: Disposition of propofol administered as constant rate intravenous infusions in human. Anesth Analg 1987;66:1256-1263
84. Jung D, Mayersohn M, Perrier D, et al: Thiopental disposition in lean and obese patients undergoing surgery. Anesthesiology 1982;56:269-274
85. Wilkes L, Danziger LH, Rodvold KA: Phenobarbital pharmacokinetics in obesity. A case report. Clin Pharmacokinet 1992;22: 481-484
86. Wulfsohn NL: Ketamine dosage for induction based on lean body mass. Anesth Analg 1972;51:299-305
87. Dursteler BB, Wightman JM: Etomidate-facilitated hip reduction in the emergency department. Am J Emerg Med 2000;18:204-208
88. Kumar V, Harvey J, Cooper GM: Does obesity affect recovery? A study using intravenous methohexitone and Althesin for short procedures. Anesthesia 1983;38:968-971
89. Choi YK, Brolin RE, Wagner BK, et al: Efficacy and safety of patient-controlled analgesia for morbidly obese patients following gastric bypass surgery. Obesity Surgery 2000;10:154-159
90. Graves DA, Batenhorst RL, Bennett RL, et al: Morphine requirements using a patient-controlled analgesia: Influence of diurnal variation and morbid obesity. Clin Pharm 1983;2:49-53
91. Egan TD, Huizinga B, Gupta SK, et al: Remifentanil pharmacokinetics in obese versus lean patients. Anesthesiology 1998;89: 562-573
92. Schwartz AE, Matteo RS, Ornstein E, et al: Pharmacokinetics of sufentanil in obese patients. Anesth Analg 1991;73:790-793
93. Dunn TE: Pharmacokinetics and pharmacodynamics of methylprednisolone in obesity. Clin Pharmacol Ther 1991;49:536-549
94. Abernethy DR: Phenytoin disposition in obesity. Determination of loading dose. Arch Neurol 1985;42:468-471
95. de Oca GM: Phenytoin dosing in obese patients two case reports. Drug Intell Clin Pharm 1988;22:708-710
96. Kuranari M: Clearance of phenytoin and valproic acid is affected by a small body weight reduction in an epileptic obese patient: A case study. J Clin Pharm Ther 1996;21:83-87
97. Suemaru K: Steady-state serum concentrations of carbamazepine and valproic acid in obese and lean patients with epilepsy. Acta Med Okayama 1998;52:139-142
98. Caraco Y: Carbamazepine pharmacokinetics in obese and lean subjects. Ann Pharmacother 1995;29:843-847
99. Poirier JM: Comparison of propranolol and sotalol pharmacokinetics in obese subjects. J Pharm Pharmacol 1990;42:344-348
100. Cheymol G: Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers. Br J Clin Pharmacol 1997;43: 563-570
101. Cheymol G: Clinical pharmacokinetics of drugs in obesity. An update. Clin Pharmacokinet 1993;25:103-114
102. Cheymol G: Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers. J Clin Pharmacol 1987; 27:874-879
103. Abernethy DR: Verapamil pharmacodynamics and disposition in obese hypertensive patients. J Cardiovasc Pharmacol 1988; 11:209-215
104. Abernethy DR: Lidocaine disposition in obesity. Am J Cardiol 1984;53:1183-1186
105. Christoff PB: Procainamide disposition in obesity. Drug Intell Clin Pharm 1983;17:516-522
106. Kowey PR, Marinchak RA, Rials SJ, et al: Classification and pharmacology of antiarrhythmic drugs. Am Heart J 2000;140:12-20
107. Abernethy DR: Digoxin disposition in obesity: Clinical pharmacokinetic investigation. Am Heart J 1981;102:740-744
108. Bearden DT, Rodvold KA: Dosage adjustments for antibacterials in obese patients. Applying clinical pharmacokinetics. Clin Pharmacokinet 2000;38:415-426
109. Traynor AM, Nafziger AN, Bertino JS: Aminoglycoside dosing weight correction fraction factors for patients of various body sizes. Antimicrob Agent Chemother 1995;39:545-548
110. Blouin RA, Mann HJ, Griffen WO, et al: Tobramycin pharmacokinetics in morbidly obese patients. Clin Pharmacol Ther 1979; 26:508-512
111. Bauer LA, Bouin RA, Griffen WO, et al: Amikacin pharmacokinetcs in morbidly obese patients. Am J Hosp Pharm 1980;37: 519-522
112. Corcoran GB, Salazar DE, Schentag JJ: Excessive aminoglycoside nephrotoxicity in obese patients. Am J Med 1988;85:279
113. Penzak SR, Gubbins PO, Rodvold KA, et al: Therapeutic drug monitoring of vancomycin in a morbidly obese patient. Ther Drug Monit 1998;20:261-265
114. Garrett ER, Suverkrup RS, Eberst K, et al: Surgically affected sulfisoxazole pharmacokinetics in the morbidly obese. Biopharm Drug Dispos 1981;2:329-365
115. Allard S, Kinzig M, Boivin G, et al: Intravenous ciprofloxzcin dispositioin in obesity. Clin Pharmacol Ther 1993;54:368-373
116. Caldwell JB, Nilsen AK: Intravenous ciprofloxacin dosing in a morbidly obese patient. Ann Pharmacother 1994;28:806
117. Prince RA, Pincheira JC, Mason EE, et al: Influence of bariatric surgery on erythromycin absorption. J Clin Pharmacol 1984; 24:523-527
118. Rex JH, Bennett JE, Sugar A, et al: A randomized trial comparing fluconazole with amphotericin for the treatment of candidemia in patients without neurtopenia. N Engl J Med 1994;331: 1325-1330
119. Cohen LG, DiBiasio A, Lisco SJ, et al: Fluconazole serum concentrations and pharmacokinetics in an obese patient. Pharmacotherapy 1997;17:1023-1026
120. st Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC (abstract 765), American Society for Microbiology, 1991
121. Acosta EP, Schwebke K, Henry K, et al: Disposition of zidovudine in obese pregnant women with human immunodeficiency virus type 1 infection. J Infect Dis 1996;174:673
122. Schaefer DC, Hufnagle J, Williams L: Rapid heparin anticoagulation: Use of a weight based nomogram. Clini Pharmacol 1996; 54:2517-2521
123. Hirsh J, Warkentin TE, Shaughnessy SG, et al: Heparin and low-molecular weight heparin. Chest 2001;119:64-94 (1 suppl)
124. Klem C, Dasta JF, Reilley TE, et al: Variability in dobutamine pharmacokinetics in unstable critically ill surgical patients. Crit Care Med 1994;22:1926-1932
125. Choban PS, Weireter LJ, Maynes C: Obesity and increased mortality in blunt trauma. J Trauma 1991;31:1253-1257
126. Blanding R, Stiff J: Perioprative anesthetic management of patients with burns. Anesthe Clini North Am 1999;17:237-250